National Lymphoma Rounds: New York

The Sheraton New York Times Square Hotel (click here for directions)
811 7th Avenue at West 53rd Street
New York, NY 10019

Thursday, October 24, 2019
6:00 PM – 9:00 PM


Morton Coleman, MD
Weill Cornell Medicine

This meeting will be held in conjunction with the Lymphoma & Myeloma Congress.

Now in its 19th year, the Lymphoma & Myeloma Congress is a comprehensive overview of industry-leading hematologic research and clinical case studies. Since its inception, this live, educational meeting has grown to more than 1,000 participants attending 4 full days of lectures, workshops, and exhibits.

Join us at the Sheraton New York Times Square Hotel October 23-26, 2019. All healthcare professionals involved with or interested in the treatment of patients with hematologic malignancies, are welcomed and encouraged to attend. Go to for more information.


6:00 PMRegistration and Networking Dinner Reception
6:45 PM Welcome and Introduction
Piper Harmon, Lymphoma Research Foundation
7:00 PM Opening Remarks
Morton Coleman, MD, Weill Cornell Medicine
7:15 PM TBA
Francesca Montanari, MD, Columbia University Medical Center
7:45 PM A Case of CLL
Richard Furman, MD, Weill Cornell Medicine
8:15 PMIntravascular B-cell Lymphoma
Shalin Kothari, MD, Yale University School of Medicine
Francine Foss, MD, Yale University School of Medicine
8:45 PMConcluding Remarks
9:00 PMAdjourn
This program is free for healthcare professionals; however, pre-registration is required. Food and refreshments will be provided for all registered participants.

Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Piper Harmon, LRF, at  Exhibit opportunities are also available, however, space is limited.

Companies that have secured a national exhibit sponsorship for Lymphoma Rounds must still rsvp by emailing Piper Harmon ( at least one week before the program to confirm their attendance. Otherwise, an exhibit table will not be guaranteed.


The Lymphoma Research Foundation’s National Lymphoma Rounds program provides a forum for healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Participants will network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts across the country.

At the conclusion of this educational activity, the participant should be better able to:

  • Summarize the latest developments in lymphoma diagnosis, treatment and management.
  • Apply best practices for treating lymphoma patients.
  • Inform patients about potential clinical trial opportunities.
  • Establish a network of health care professionals who work with lymphoma patients.
Other dates in the 2019-20 Rounds series:

  • Wednesday, February 5, 2020
  • Wednesday, April 15, 2020

New York Lymphoma Rounds Steering Committee

Columbia University Medical Center
Owen O’Connor, MD, PhD
Francesca Montanari, MD
Hackensack University Medical Center
Andre Goy, MD, MS
Icahn School of Medicine at Mount Sinai
Josh Brody, MD
Memorial Sloan Kettering Cancer Center
Anthony Mato, MD, MSCE
David Straus, MD (chair)
NYU Langone Medical Center
Catherine Diefenbach, MD
Rutgers Cancer Institute of New Jersey
Joseph Bertino, MD
Andrew Evens, DO, MSc, FACP
Weill Cornell Medicine
Koen van Besien, MD, PhD
Ethel Cesarman, MD, PhD
Amy Chadburn, MD
Morton Coleman, MD

Joint Providership Statement

This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and the Lymphoma Research Foundation.

Accreditation Statement

The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Statement

The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Lymphoma Research Foundation and the University of Nebraska Medical Center, Center for Continuing Education

This activity is supported by educational grants from:
Acrotech Biopharma, LLC, AstraZeneca, Celgene Corporation, Janssen Scientific Affairs, LLC and Pharmacyclics, LLC, an AbbVie Company, Novartis Pharmaceuticals Corporation, Seattle Genetics, Inc., TG Therapeutics, Inc. and Verastem, Inc.